Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Breast Cancer Research and Treatment
Published September 21, 2026
Equivalent survival in targeted axillary dissection compared to axillary lymph node dissection in...
September 22, 2026
Medspoke
Medspoke
The Oncologist
Published September 21, 2026
00:00
--:--
Comparative safety of concurrent adjuvant trastuzumab emtansine versus trastuzumab with radiother...
September 22, 2026
Share
Comparative safety of concurrent adjuvant trastuzumab emtansine versus trastuzumab with radiotherapy in HER2-positive early breast cancer.
https://www.medspoke.co/channel_journal?id=795&tap_id=14288
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Colorectal Cancer
Published August 19, 2026
Efficacy and Safety of Immune Checkpoint Inhibitor-Based Neoadjuvant Therapy Combinations in Prof...
September 22, 2026
Why are you reporting this TALK?
